Richard Layese

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

Pierre Nahon, Richard Layese, Valérie Bourcier et al. · Gastroenterology · 2018 · 237 citations · Full text

Medicine, Infectious Diseases, Hepatology +15

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC

Andrea Notarpaolo, Richard Layese, Paolo Magistri et al. · Journal of Hepatology · 2016 · 220 citations · Full text

Medicine, Internal Medicine, Hepatology +13

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Dominique Roulot, Ségolène Brichler, Richard Layese et al. · Journal of Hepatology · 2020 · 154 citations

Life Sciences, Infectious Diseases, Hepatology +16

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

Dominique Thabut, Christophe Bureau, Richard Layese et al. · Gastroenterology · 2019 · 131 citations · Full text

Medicine, Internal Medicine, Disease Surveillance +16

Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States

Benjamin Cadier, Julie Bulsei, Pierre Nahon et al. · Hepatology · 2017 · 122 citations

Pharmacy, Oncology, Pharmacoeconomics +17